Androgen receptor expression as a prognostic and predictive marker in triple-negative breast cancer patients
Purpose: It is clear that triple-negative breast cancer (TNBC) tumors are heterogeneous group, but clinically important sub-sets have begun to emerge. We investigate the immunohistochemical expression of androgen receptor (AR) among those hormonal insensitive groups which have only the option of che...
Main Authors: | Fatma Zakaria, Nehal El-Mashad, Dareen Mohamed |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2016-06-01
|
Series: | Alexandria Journal of Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090506815000469 |
Similar Items
-
Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
by: Maša Brumec, et al.
Published: (2021-04-01) -
Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
by: Mirco Pistelli, et al.
Published: (2014-06-01) -
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease
by: Maria Vittoria Dieci, et al.
Published: (2019-06-01) -
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
by: Shristi Bhattarai, et al.
Published: (2019-07-01) -
Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01)